
SPECIAL REPORT: Update on the Johnson & Johnson COVID-19 Vaccine and Blood Clot Risk
Dr. Derek Stitt speaks with FDA Center for Biologics Evaluation and Research Director Dr. Peter Marks about cases of thrombosis after the Johnson & Johnson COVID-19 vaccine, potential risk factors, and suggestions for patient care.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.